Abstract
We investigated the clinical impact of the purified protein derivative skin test prior to bacillus Calmette-Guérin therapy in patients with nonmuscle invasive bladder cancer treated with adjuvant bacillus Calmette-Guérin therapy. A total of 498 patients with nonmuscle invasive bladder cancer treated with adjuvant bacillus Calmette-Guérin were included in study, of whom 320 underwent the purified protein derivative skin test 1 to 2 weeks prior to therapy. Oncologic outcomes and the rate of bacillus Calmette-Guérin related side effects were statistically evaluated. The mean ± SD 5-year recurrence-free survival rate in patients who did vs did not undergo the purified protein derivative skin test was 66.6% ± 2.8% and 59.1% ± 4.1%, respectively, which was significantly different (p = 0.048). No significant difference was observed in the progression-free survival rate between patients who did vs did not undergo the test. Multivariate Cox regression analysis revealed that a history of recurrence (HR 1.59, p = 0.02), multiple tumors (HR 1.95, p <0.01), the bacillus Calmette-Guérin Connaught strain (HR 0.71, p = 0.04), 7 or more bacillus Calmette-Guérin instillations (HR 0.70, p = 0.04) and undergoing the purified protein derivative ski...Continue Reading
References
Mar 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R A BadalamentH F Oettgen
Nov 1, 1982·The Journal of Urology·D L LammH M Radwin
Jan 5, 1999·American Journal of Respiratory and Critical Care Medicine·D Menzies
May 21, 1999·Lancet·A B AlexandroffK James
Mar 24, 2004·European Urology·Antonio Lopez-BeltranRodolfo Montironi
Mar 8, 2006·Vaccine·Carol Goter-RobinsonSheldon L Morris
Sep 14, 2006·Clinical and Experimental Immunology·Y LuoX Chen
Feb 24, 2009·Urology·Toshikazu TakedaMototsugu Oya
Mar 10, 2009·Seminars in Immunology·Megan K L MacLeodPhilippa Marrack
Apr 27, 2012·Seminars in Immunopathology·Shuo-Wang QiaoLudvig M Sollid
Jun 8, 2012·Science Translational Medicine·Claire BiotMatthew L Albert
Dec 21, 2012·BJU International·Baerin B HoughtonMartin R Stockler
Feb 5, 2014·Nature Reviews. Urology·Gil Redelman-SidiBernard H Bochner
Jun 19, 2016·The Journal of Urology·Sam S ChangJames M McKiernan
Jun 22, 2016·European Urology·Marko BabjukRichard Zigeuner
Oct 5, 2016·Journal of the National Comprehensive Cancer Network : JNCCN·Peter E ClarkCourtney Smith
Jan 24, 2017·Cancer·Vignesh T PackiamGary D Steinberg
Nov 4, 2017·Urologic Oncology·Naoya NiwaMototsugu Oya
Citations
Feb 15, 2019·Current Opinion in Urology·Neelam MukherjeeRobert S Svatek
Oct 30, 2019·International Journal of Urology : Official Journal of the Japanese Urological Association·Hiroshi Fukushima, Yasuhisa Fujii
Jul 18, 2020·Nature Reviews. Urology·Jelmer H van PuffelenSita H Vermeulen
May 19, 2019·The Journal of Pathology·Dongkui SongYong-Jie Lu
Dec 3, 2020·Urologic Oncology·John P SfakianosAmir Horowitz
Aug 3, 2021·European Urology Open Science·Satoru MutoShigeo Horie